These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31721437)

  • 1. Dakin's solution in the treatment of severe diabetic foot infections.
    Duarte B; Formiga A; Neves J
    Int Wound J; 2020 Apr; 17(2):277-284. PubMed ID: 31721437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dakin's solution: is there a place for it in the 21st century?
    Duarte B; Cabete J; Formiga A; Neves J
    Int Wound J; 2017 Dec; 14(6):918-920. PubMed ID: 28198104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical review of Dakin's solution applications.
    Ueno CM; Mullens CL; Luh JH; Wooden WA
    J Plast Reconstr Aesthet Surg; 2018 Sep; 71(9):e49-e55. PubMed ID: 30173720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dakin's solution: historical perspective and current practice.
    McCullough M; Carlson GW
    Ann Plast Surg; 2014 Sep; 73(3):254-6. PubMed ID: 25121415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Diluted Dakin's Solution Versus Standard Care on Diabetic Foot Ulcer Management: A Randomized Controlled Trial.
    Jaber D; Younes N; Khalil E; Albsoul-Younes A; Mismar A; Nassar M; Al-Bakri AG
    J Am Podiatr Med Assoc; 2022 Mar; 112(1):. PubMed ID: 34233350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid degradation and non-selectivity of Dakin's solution prevents effectiveness in contaminated musculoskeletal wound models.
    Mangum LC; Franklin NA; Garcia GR; Akers KS; Wenke JC
    Injury; 2018 Oct; 49(10):1763-1773. PubMed ID: 30104015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A severely infected diabetic foot treated successfully without using systemic antibiotics.
    Tian M; Jiang YZ; Niu YW; Xiao YR; Lu SL; Wang XQ
    Int J Low Extrem Wounds; 2012 Dec; 11(4):296-8. PubMed ID: 23089961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of Dakin's solution in chronic wounds: a clinical perspective case series.
    Cornwell P; Arnold-Long M; Barss SB; Varnado MF
    J Wound Ostomy Continence Nurs; 2010; 37(1):94-104. PubMed ID: 20075698
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dakin's solution].
    St-Cyr D
    Perspect Infirm; 2010; 7(4):33. PubMed ID: 20653309
    [No Abstract]   [Full Text] [Related]  

  • 10. A simple and effective approach for the treatment of diabetic foot ulcers with different Wagner grades.
    Nagoba BS; Gandhi RC; Wadher BJ; Rao A; Hartalkar AR; Selkar SP
    Int Wound J; 2010 Jun; 7(3):153-8. PubMed ID: 20455958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open-label, three-arm pilot study of the safety and efficacy of topical Microcyn Rx wound care versus oral levofloxacin versus combined therapy for mild diabetic foot infections.
    Landsman A; Blume PA; Jordan DA; Vayser D; Gutierrez A
    J Am Podiatr Med Assoc; 2011; 101(6):484-96. PubMed ID: 22106196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified Dakin's solution for cutaneous vibrio infections.
    Wilhelmi BJ; Calianos TA; Appelt EA; Ortiz ME; Heggers JP; Phillips LG
    Ann Plast Surg; 1999 Oct; 43(4):386-9. PubMed ID: 10517465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Dakin's solution on components of a dermal equivalent.
    Vick LR; Propst RC; Bozeman R; Wysocki AB
    J Surg Res; 2009 Jul; 155(1):54-64. PubMed ID: 19394965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can We Stop Antibiotic Therapy When Signs and Symptoms Have Resolved in Diabetic Foot Infection Patients?
    Chu Y; Wang C; Zhang J; Wang P; Xu J; Ding M; Li X; Hou X; Feng S; Li X
    Int J Low Extrem Wounds; 2015 Sep; 14(3):277-83. PubMed ID: 26248828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical therapy of diabetic foot infections.
    Joseph WS; Lipsky BA
    J Am Podiatr Med Assoc; 2010; 100(5):395-400. PubMed ID: 20847353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Long-Term Outcomes Following the Application of Intralesional Epidermal Growth Factor in Patients With Diabetic Foot Ulcers.
    Kahraman M; Misir A; Kizkapan TB; Ozcamdalli M; Uzun E; Mutlu M
    J Foot Ankle Surg; 2019 Mar; 58(2):282-287. PubMed ID: 30612874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and Risk Factors Associated With Ulcer Recurrence Among Patients With Diabetic Foot Ulcers Treated in a Multidisciplinary Setting.
    Hicks CW; Canner JK; Mathioudakis N; Lippincott C; Sherman RL; Abularrage CJ
    J Surg Res; 2020 Feb; 246():243-250. PubMed ID: 31610352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dakin's solution in wound treatment.
    Arch Surg; 1988 Dec; 123(12):1525-6. PubMed ID: 3190435
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of dilute Dakin's solution for the treatment of angioinvasive fungal infection in the combat wounded: a case series.
    Lewandowski L; Purcell R; Fleming M; Gordon WT
    Mil Med; 2013 Apr; 178(4):e503-7. PubMed ID: 23707840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined primary subintimal and endoluminal angioplasty for ischaemic inferior-limb ulcers in diabetic patients: 5-year practice in a multidisciplinary 'diabetic-foot' service.
    Alexandrescu V; Hubermont G; Philips Y; Guillaumie B; Ngongang Ch; Coessens V; Vandenbossche P; Coulon M; Ledent G; Donnay JC
    Eur J Vasc Endovasc Surg; 2009 Apr; 37(4):448-56. PubMed ID: 19213580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.